ADALIMUMAB

Course overview

ADALIMUMAB IS A FULLY HUMAN, HIGH-AFFINITY, RECOMBINANT ANTI-TUMOR NECROSIS FACTOR (TNF) ALPHA MONOCLONAL ANTIBODY USED TO TREAT RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, PSORIASIS, PSORIATIC ARTHRITIS, CROHN DISEASE, ULCERATIVE COLITIS, ETC. THIS ACTIVITY COVERS THE INDICATIONS, MECHANISM OF ACTION, DOSING, CONTRAINDICATIONS, AND ADVERSE EVENTS OF THIS DRUG, AS NEEDED BY THE INTERPROFESSIONAL HEALTHCARE TEAM MEMBERS TO UTILIZE IT EFFECTIVELY FOR PATIENT TREATMENT.